Scientia Professor

George Paxinos

AO FAA

George Paxinos
Image Description
Professor George Paxinos is currently funded by two national and two international agencies to construct atlases of the brain and spinal cord. He published 34 books and 146 articles in refereed journals and 28 book chapters. He discovered more nuclei (brain structures) and homologies in mammals and birds than anyone in nearly 100 years. All his atlases are characterised by excellence, with his first work, The Rat Brain in Stereotaxic Coordinates, being the most cited Australian publication and the only neuroscience publication in the Thomson 50 most cited list. The total number of citations for all his works is 53,904.

Fields of research

32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3209 NEUROSCIENCES

For full list of research codes, please visit the ARC Website .

Expertise type

  • Brain Function
  • Brain Structure
  • Medical Sciences
  • Neuroscience

Please contact fellowship@science.org.au to request any updates to the data.

Professor

David Cooper

AC FAA FAHMS

David Cooper
Image Description
Professor Cooper is one of the most influential clinical scientists worldwide in the field of HIV/AIDS. Shortly after the Human Immunodeficiency Virus (HIV) was discovered in 1984, he published a seminal paper in the prestigious medical journal The Lancet, which described the initial encounter of HIV with the human immune system. He has been a key investigator in proving the efficacy of highly active antiretroviral therapy and implementing its benefits. He is one of the first clinical scientists to recognize the metabolic toxicities of antiretroviral therapy and to contribute to an understanding of the pathogenesis. Moreover, Professor Cooper has been instrumental in the international fight against HIV/AIDS in the developing world.

Expertise type

  • Antiretroviral Therapy
  • HIV AIDS
  • Infectious Diseases
  • Medical Sciences

Please contact fellowship@science.org.au to request any updates to the data.

Professor

David Celermajer

AO FAA FAHMS

David Celermajer
Image Description
David Celermajer’s seminal contribution to science has been the invention of a technique to allow the study of the arterial endothelium in humans, and subsequently the first ever demonstration that arterial damage can occur in children and young adults at risk of vascular disease, e.g. in association with passive smoking and obesity, many years before the disease causes complications such as heart attack or stroke. This identification of pre-symptomatic arterial damage has revolutionised the field of cardiovascular prevention and has led to novel treatment options (such as oral L-arginine and inhaled nitric oxide) for patients with early arterial damage.

Fields of research

32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY
    • 320101 Cardiology (incl. Cardiovascular Diseases)

For full list of research codes, please visit the ARC Website .

Expertise type

  • Cardiovascular Disease
  • Endothelial Dysfunction
  • Medical Sciences
  • Vascular Biology
  • Pulmonary hypertension
  • Medical Devices
  • Registries
  • Adult congenital heart disease
  • Big data

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Ian Frazer

AC FAA FTSE FAHMS FRS

Ian Frazer
Image Description
Dr Frazer has spent 15 years developing prophylactic and therapeutic vaccines, with particular focus on prevention and treatment of papillomavirus associated cervical cancer. He developed a virus like particle based vaccine for prevention of papillomavirus infection which has shown 100% efficacy in late stage international clinical trials. He also developed a therapeutic vaccine for cervical pre-cancer, which is in clinical trail in Australia, and has proven efficacious in a number of animal models. His basic research in tumour immunology has provided insight into the problems of inducing immunity to antigens expressed in somatic cells without associated inflammation.

Fields of research

32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3204 IMMUNOLOGY
    • 320409 Tumour Immunology
44 HUMAN SOCIETY
  • 4499 Other human society

For full list of research codes, please visit the ARC Website .

Expertise type

  • Immunology
  • Medical Sciences
  • Pathology
  • Virology

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Mark von Itzstein

AO FAA FAHMS

Mark von Itzstein
Image Description
Professor von Itztein’s career as a carbohydrate scientist began in 1986, when he joined the Melbourne team working on influenza drug discovery. His success in 1989 in the design and synthesis of zanamivir, now marketed under the name Relezna, was achieved at a time when there were few examples of inhibitor-design based on the three-dimensional structure of an enzyme. He was jointly awarded the Australia Prize for pharmaceutical design in 1996, and in 2001 received the prestigious Alexander von Humboldt Forschungpreis for foreign scholars. He has published and patented extensively in glycoscience, and established strong collaborations locally and internationally.

Fields of research

31 BIOLOGICAL SCIENCES
  • 3101 BIOCHEMISTRY AND CELL BIOLOGY
    • 310112 Structural Biology (incl. Macromolecular Modelling)
  • 3107 MICROBIOLOGY
    • 310706 Virology
34 CHEMICAL SCIENCES
  • 3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY

For full list of research codes, please visit the ARC Website .

Expertise type

  • Influenza Virus
  • Virus Infection
  • Biochemistry
  • Chemistry
  • Drug Design
  • Glycosides
  • Medicinal Chemistry
  • Chemical biology

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Max Coltheart

AM FAA FASSA

Max Coltheart
Image Description
Professor Coltheart's distinguished experimental research in cognitive neuropsychology and his theoretical contributions have established him as a leading world authority, particularly in the neuropsychology of reading disability (dyslexia) and disorders of semantic memory and language. His widely cited research has had a major impact in shaping the work of others in Australia and in major research centres abroad and is generally acknowledged as leading to a much clearer understanding of the nature of language and memory disorders and appropriate means for their treatment. He is the Founding Editor (1984) and Editor-in-Chief of Cognitive Neuropsychology, the most influential journal in its field, and has served (1972-1985) as Editor of the British Journal of Psychology and as President of the Experimental Psychology Society in the UK (1985-1987).

Fields of research

52 PSYCHOLOGY

For full list of research codes, please visit the ARC Website .

Expertise type

  • Neuropsychology
  • Neuropsychiatry
  • Cognitive Science
  • Medical Sciences
  • Neuroscience
  • Psychology

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Bruce Armstrong

AM FAA

Bruce Armstrong
Image Description
Dr Armstrong is a public health scientist who has used quantitative methods in his scientific contributions to epidemiology, especially in the field of cancer epidemiology. He has advanced our knowledge of the epidemiology, aetiology and control of malignant melanoma of the skin, studied the role of diet in human carcinogenesis in relation to cancers of the breast and endometrium, and considered the epidemiology and control of asbestos-related cancer. He has also clarified the relationship of diet and alcohol to blood pressure, and analyzed technical aspects of exposure measurement in epidemiological research. Dr Armstrong is arguably the most outstanding public health scientist in the history of Australian epidemiology.

Fields of research

32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3211 ONCOLOGY AND CARCINOGENESIS
    • 321199 Oncology and Carcinogenesis not elsewhere classified
42 HEALTH SCIENCES
  • 4202 EPIDEMIOLOGY
  • 4203 HEALTH SERVICES AND SYSTEMS
    • 420305 Health and Community Services
    • 420399 Public Health and Health Services not elsewhere classified
  • 4206 PUBLIC HEALTH
    • 420605 Preventative health care

For full list of research codes, please visit the ARC Website .

Expertise type

  • Medical Sciences
  • Cancer Risk
  • Public Health
  • Community Health
  • Disadvantaged/High-Risk Populations
  • Epidemiology
  • Genetic Epidemiology
  • Melanoma
  • Cancer

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Barry Marshall

AC FAA FAHMS FRS Nobel Laureate

Barry Marshall
Image Description
Professor Marshall discovered that infection of the stomach with uncharacterised spiral bacteria caused gastritisdyspepsia and gastroduodenal ulceration, and predisposes to gastric cancer. This profound discovery was a remarkable fulfilment of Koch's postulates, based on astute clinical and laboratory observations combined with a dramatic self-infection experiment showing conclusively that cultured bacteria induced gastritis. Marshall characterised the ulcerogenic bacterium as a new species Helicobacter Pylori established growth dependence on urea and developed diagnostic tests for its presence and eradication. His observations are a major contribution to microbiology, have revolutionised treatment of gastroduodenal ulcers, by enabling cure with antibiotics, and will substantially reduce the prevalence of gastric cancer.

Expertise type

  • Gastroenterology
  • Helicobacter Pylori
  • Medical Sciences
  • Microbiology

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Colin Masters

AO FAA FTSE FAHMS

Colin Masters
Image Description
Professor Masters is distinguished for his outstanding contributions to the study of amyloid deposition in the brains of patients with degenerative brain conditions, especially in Alzheimer's disease. He purified the amyloid plaques from Alzheimer brains and cooperated with Beyreuther in determining its amino-acid sequence and in cloning the gene coding for the amyloid precursor protein, APP. Mutations of the gene, on chromosome 21, have now been shown to cause forms of familial Alzheimer's disease. The detailed study of the processing pathways involving APP has identified rational therapeutic targets for treatment of Alzheimer's disease and prevention of its onset.

Expertise type

  • Alzheimer's disease
  • Creutzfeldt-Jacob Disease
  • Medical Sciences
  • Neurodegenerative Disease
  • Neuroscience

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Colin Sullivan

FAA

Colin Sullivan
Image Description
Professor Sullivan is recognised as an international leader in the field of sleep disordered breathing. His major research achievements include characterising the basic physiology of breathing during sleep and the recognition that arousal responses from sleep are crucial to survival in respiratory failure. He has been the key person in Australia promoting the investigation of sleep disorders medicine and he established the first diagnostic sleep laboratories for adults and children. He is known internationally for developing nasal continuous positive airway pressure to treat obstructive sleep apnea. This is now the most widely used treatment for this disease throughout the world.

Expertise type

  • CPAP
  • Medical Devices
  • Medical Sciences
  • Respiratory Medicine
  • Sleep Apnea

Please contact fellowship@science.org.au to request any updates to the data.